SAN DIEGO, May 16, 2022 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced the appointment of Laurie Stelzer as the Company’s Chief Financial Officer (CFO) effective May 16, 2022. […]
After halting enrollment in an NIH-led Phase II/III study, and failing an earlier Phase III trial, UK-based Synairgen’s Covid-19 drug did show some promise in some select subgroups, the company said in its presentation of […]
COVID-19, MIS-C and KD all share a similar underlying mechanism involving the over-activation of particular inflammatory pathways, UC San Diego study shows. Findings support novel drug targets for MIS-C. Click here to view original post
SAN DIEGO and SHANGHAI, May 15, 2022 /PRNewswire/ — Inmagene Biopharmaceuticals (“Inmagene”) announces that today the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application for the drug candidate IMG-004, a […]
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]
Delaware federal jury found that Illumina infringed on two patents of Complete Genomics, a U.S. subsidiary of Chinese firm BGI. The San Diego gene sequencing market leader says it will appeal Click here to view […]
LA JOLLA—The Salk Institute was proud to host French luxury fashion house Louis Vuitton and guests on May 12 for a private fashion show presenting the brand’s Cruise 2023 collection. The show was the first […]
Johannes Eichstaedt, a computational social scientist and faculty fellow at the Stanford Institute for Human-Centered Artificial Intelligence, uses social media data and machine learning to gain insight into a wide range of health-related issues. Click […]
Last weekend, Sanford Burnham Prebys helped support local cancer research by participating in Padres Pedal the Cause. Click here to view original post
Novel oncology microbiome and psychiatric disorder therapeutics backed by a range of discovery & development tools from AI to microgravity – all featured on the swisstech pavilion at BIO 2022 in San Diego, June 13-16 […]
© 2022 Biotech Networks, LLC
